Acne in the adult female often presents as a chronic condition that can have a considerable negative psychological, social and emotional impact on the affected individual. Estimated prevalence rates of adult female acne vary widely according to study type. Case reports and clinical examinations estimate the prevalence of clinical acne at 10-12%, while survey estimates of physiological disease states are as high as 54%. Two subtypes of adult female acne may be defined according to time of onset: ‘persistent' and ‘late-onset', accounting for approximately 80 and 20% of cases, respectively. Postadolescent acne is generally mild-to-moderate in severity and presents with more inflammatory lesions and fewer comedones compared to adolescent acne. Furthermore, the impact of acne on the quality of life is often greater in adult females than in younger individuals. Despite these important differences, the key principles of acne treatment in the adult female do not differ significantly from those of other age groups. However, specific characteristics relating to the adult female should be considered when selecting a treatment regimen.

Keywords:
Adult female, Acne, Hormones, Prevalence, Treatment
1.
Goulden V, Stables GI, Cunliffe WJ: Prevalence of facial acne in adults. J Am Acad Dermatol 1999;41:577-580.
2.
Plunkett A, Merlin K, Gill D, Zuo Y, Jolley D, Marks R: The frequency of common nonmalignant skin conditions in adults in central Victoria, Australia. Int J Dermatol 1999;38:901-908.
3.
Goodman G: Managing acne vulgaris effectively. Aust Fam Physician 2006;35:705-709.
4.
Choi C, Lee DH, Kim HS, Kim BY, Park KC, Youn SW: The clinical features of late onset acne compared with early onset acne in women. J Eur Acad Dermatol Venereol 2011;25:454-461.
5.
Dreno B: Recent data on epidemiology of acne (in French). Ann Dermatol Venereol 2010;137(suppl 2):S49-S51.
6.
Perkins A, Cheng C, Hillebrand G, Miyamoto K, Kimball A: Comparison of the epidemiology of acne vulgaris among Caucasian, Asian, Continental Indian and African American women. J Eur Acad Dermatol Venereol 2011;25:1054-1060.
7.
Collier CN, Harper JC, Cafardi JA, Cantrell WC, Wang W, Foster KW, Elewski BE: The prevalence of acne in adults 20 years and older. J Am Acad Dermatol 2008;58:56-59.
8.
Cunliffe WJ, Gould DJ: Prevalence of facial acne vulgaris in late adolescence and in adults. Br Med J 1979;1:1109-1110.
9.
Goulden V, McGeown CH, Cunliffe WJ: The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals. Br J Dermatol 1999;141:297-300.
10.
Lasek RJ, Chren MM: Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol 1998;134:454-458.
11.
Tan JK, Li Y, Fung K, Gupta AK, Thomas DR, Sapra S, Lynde C, Poulin Y, Gulliver W, Sebaldt RJ: Divergence of demographic factors associated with clinical severity compared with quality of life impact in acne. J Cutan Med Surg 2008;12:235-242.
12.
Rivera R, Guerra A: Management of acne in women over 25 years of age (in Spanish). Actas Dermosifiliogr 2009;100:33-37.
13.
Williams C, Layton AM: Persistent acne in women: implications for the patient and for therapy. Am J Clin Dermatol 2006;7:281-290.
14.
Capitanio B, Sinagra JL, Bordignon V, Cordiali Fei P, Picardo M, Zouboulis CC: Underestimated clinical features of postadolescent acne. J Am Acad Dermatol 2010;63:782-788.
15.
Goulden V, Clark SM, Cunliffe WJ: Post-adolescent acne: a review of clinical features. Br J Dermatol 1997;136:66-70.
16.
White GM: Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris. J Am Acad Dermatol 1998;39:S34-S37.
17.
Knaggs HE, Wood EJ, Rizer RL, Mills OH: Post-adolescent acne. Int J Cosmet Sci 2004;26:129-138.
18.
Stern RS: The prevalence of acne on the basis of physical examination. J Am Acad Dermatol 1992;26:931-935.
19.
Poli F, Dreno B, Verschoore M: An epidemiological study of acne in female adults: results of a survey conducted in France. J Eur Acad Dermatol Venereol 2001;15:541-545.
20.
Shaw JC, White LE: Persistent acne in adult women. Arch Dermatol 2001;137:1252-1253.
21.
Schaefer I, Rustenbach SJ, Zimmer L, Augustin M: Prevalence of skin diseases in a cohort of 48,665 employees in Germany. Dermatology 2008;217:169-172.
22.
Yentzer BA, Hick J, Reese EL, Uhas A, Feldman SR, Balkrishnan R: Acne vulgaris in the United States: a descriptive epidemiology. Cutis 2010;86:94-99.
23.
Choi CW, Lee DH, Kim HS, Kim BY, Park KC, Youn SW: The clinical features of late onset acne compared with early onset acne in women. J Eur Acad Dermatol Venereol 2011;25:454-461.
24.
Kligman AM: Postadolescent acne in women. Cutis 1991;48:75-77.
25.
Tian LM, Xie HF, Yang T, Hu YH, Li J: Correlation between CYP17 gene polymorphisms and female postadolescent acne in Han population in Hunan Province (in Chinese). Nan Fang Yi Ke Da Xue Xue Bao 2010;30:1590-1592.
26.
Cappel M, Mauger D, Thiboutot D: Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women. Arch Dermatol 2005;141:333-338.
27.
Seirafi H, Farnaghi F, Vasheghani-Farahani A, Alirezaie NS, Esfahanian F, Firooz A, Ghodsi SZ: Assessment of androgens in women with adult-onset acne. Int J Dermatol 2007;46:1188-1191.
28.
Borgia F, Cannavo S, Guarneri F, Cannavo SP, Vaccaro M, Guarneri B: Correlation between endocrinological parameters and acne severity in adult women. Acta Derm Venereol 2004;84:201-204.
29.
Sheehan-Dare RA, Hughes BR, Cunliffe WJ: Clinical markers of androgenicity in acne vulgaris. Br J Dermatol 1988;119:723-730.
30.
Aizawa H, Niimura M: Elevated serum insulin-like growth factor-1 (IGF-1) levels in women with postadolescent acne. J Dermatol 1995;22:249-252.
31.
Stoll S, Shalita AR, Webster GF, Kaplan R, Danesh S, Penstein A: The effect of the menstrual cycle on acne. J Am Acad Dermatol 2001;45:957-960.
32.
Arora MK, Seth S, Dayal S: The relationship of lipid profile and menstrual cycle with acne vulgaris. Clin Biochem 2010;43:1415-1420.
33.
Savage LJ, Layton AM: Treating acne vulgaris: systemic, local and combination therapy. Expert Rev Clin Pharmacol 2010;13:563-580.
34.
Cunliffe WJ: Acne and unemployment. Br J Dermatol 1986;115:386.
35.
Dreno B, Layton A, Zouboulis CC, Lopez-Estebaranz JL, Zalewska-Janowska A, Bagatin E, Zampeli VA, Yutskovskaya Y, Harper JC: Adult female acne: a new paradigm. J Eur Acad Dermatol Venereol 2013;27:1063-1070.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.